Morgan Stanley Maintains Overweight on Moelis, Lowers Price Target to $77

Benzinga Newsdesk www.benzinga.com Negative 68.8%

Neg 68.8% Neu 0% Pos 0%

Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:MC) with a Overweight and lowers the price target from $85 to $77.